PharmaCyte Biotech (PMCB) Price to Sales (2013)
PharmaCyte Biotech's (PMCB) Price to Sales came in at 19459533.87 for fiscal Q1 2014 (quarter ended Jul 31, 2013), up 255.8% from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Price to Sales (2013) Analysis & Trends
For FY2013 (ended Apr 30, 2013), PharmaCyte Biotech's Price to Sales stood at 5807478.27.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | PharmaCyte Biotech | 4.40 Mn | 4.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2013 | 19.46 Mn |
| Apr 30, 2013 | 5.47 Mn |
| Jan 31, 2013 | 981,840.22 |
API Access
PharmaCyte Biotech Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();